Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell re...

Por Haaland, Benjamin, Chopra, Akhil, Acharyya, Sanchalika, Fay, André P, Lopes, Gilberto de Lima
Publicado em 2014

10% Tumor Diameter Shrinkage on the First Follow-Up Computed Tomography Predicts Clinical Outcome in Patients With Advanced Renal Cell Carcinoma Treated With Angiogenesis Inhibitor...

Por Krajewski, Katherine M., Franchetti, Yoko, Nishino, Mizuki, Fay, André P., Ramaiya, Nikhil, Van den Abbeele, Annick D., Choueiri, Toni K.
Publicado em 2014

Adrenocortical Carcinoma: The Management of Metastatic Disease

Por Fay, André P., Elfiky, Aymen, Teló, Gabriela H., McKay, Rana R., Kaymakcalan, Marina, Nguyen, Paul L., Vaidya, Anand, Ruan, Daniel T., Bellmunt, Joaquim, Choueiri, Toni K.
Publicado no Crit Rev Oncol Hematol (2014)

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothe...

Por Bellmunt, Joaquim, Werner, Lillian, Leow, Jeffrey J., Mullane, Stephanie A., Fay, André P., Riester, Markus, Van Hummelen, Paul, Taplin, Mary-Ellen, Choueiri, Toni K., Van Allen, Eliezer, Rosenberg, Jonathan
Publicado no PLoS One (2015)

BRAF mutations in metanephric adenoma of the kidney

Por Choueiri, Toni K., Cheville, John, Palescandolo, Emanuele, Fay, Andre P., Kantoff, Philip W., Atkins, Michael B., McKenney, Jesse K., Brown, Victoria, Lampron, Megan E., Zhou, Ming, Hirsch, Michelle S., Signoretti, Sabina
Publicado no Eur Urol (2012)

The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma

Por Choueiri, Toni K., Fay, André P., Gagnon, Robert, Lin, Ying, Bahamon, Brittany, Brown, Victoria, Rosenberg, Jonathan E., Hutson, Thomas E., Baker-Neblett, Katherine L., Carpenter, Christopher, Liu, Yuan, Pandite, Lini, Signoretti, Sabina
Publicado no Clin Cancer Res (2013)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy

Por Bellmunt, Joaquim, Zhou, Chensheng Willa, Mullane, Stephanie A, Werner, Lillian, Taplin, Mary-Ellen, Fay, André P, Choueiri, Toni K, Orsola, Anna, Takeda, David Y, Hahn, William C, Kim, Jaegil, Sonpavde, Guru, Bowden, Michaela
Publicado no Br J Cancer (2016)

Differential expression of PD-L1 between primary and metastatic sites in clear cell Renal Cell Carcinoma

Por Callea, Marcella, Albiges, Laurence, Gupta, Mamta, Cheng, Su-Chun, Genega, Elizabeth M., Fay, André P., Song, Jiaxi, Carvo, Ingrid, Bhatt, Rupal S., Atkins, Michael B., Hodi, F. Stephen, Choueiri, Toni K., McDermott, David F., Freeman, Gordon J., Signoretti, Sabina
Publicado no Cancer Immunol Res (2015)

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

Por Fay, André P, Signoretti, Sabina, Callea, Marcella, Telό, Gabriela H, McKay, Rana R, Song, Jiaxi, Carvo, Ingrid, Lampron, Megan E, Kaymakcalan, Marina D, Poli-de-Figueiredo, Carlos E, Bellmunt, Joaquim, Hodi, F Stephen, Freeman, Gordon J, Elfiky, Aymen, Choueiri, Toni K
Publicado no J Immunother Cancer (2015)

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model

Por de Velasco, Guillermo, Culhane, Aedín C., Fay, André P., Hakimi, A. Ari, Voss, Martin H., Tannir, Nizar M., Tamboli, Pheroze, Appleman, Leonard J., Bellmunt, Joaquim, Kimryn Rathmell, W., Albiges, Laurence, Hsieh, James J., Heng, Daniel Y. C., Signoretti, Sabina, Choueiri, Toni K.
Publicado no Oncologist (2017)

Identification of ALK Gene Alterations in Urothelial Carcinoma

Por Bellmunt, Joaquim, Selvarajah, Shamini, Rodig, Scott, Salido, Marta, de Muga, Silvia, Costa, Irmgard, Bellosillo, Beatriz, Werner, Lillian, Mullane, Stephanie, Fay, André P., O'Brien, Robert, Barretina, Jordi, Minoche, André E., Signoretti, Sabina, Montagut, Clara, Himmelbauer, Heinz, Berman, David M., Kantoff, Philip, Choueiri, Toni K., Rosenberg, Jonathan E.
Publicado em 2014

HER2 as a target in invasive urothelial carcinoma

Por Bellmunt, Joaquim, Werner, Lillian, Bamias, Aristotle, Fay, André P, Park, Rachel S, Riester, Markus, Selvarajah, Shamini, Barletta, Justine A, Berman, David M, de Muga, Silvia, Salido, Marta, Gallardo, Enrique, Rojo, Federico, Guancial, Elizabeth A, Bambury, Richard, Mullane, Stephanie A, Choueiri, Toni K, Loda, Massimo, Stack, Edward, Rosenberg, Jonathan
Publicado no Cancer Med (2015)

Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic Renal Cell Carcinoma

Por Kwiatkowski, David J., Choueiri, Toni K., Fay, André P., Rini, Brian I., Thorner, Aaron R., de Velasco, Guillermo, Tyburczy, Magdalena E., Hamieh, Lana, Albiges, Laurence, Agarwal, Neeraj, Ho, Thai H., Song, Jiaxi, Pignon, Jean-Christophe, Barrios, Pablo M., Michaelson, M. Dror, Van Allen, Eliezer, Krajewski, Katherine M., Porta, Camillo, Pal, Sumanta, Bellmunt, Joaquim, McDermott, David F., Heng, Daniel Y. C., Gray, Kathryn P., Signoretti, Sabina
Publicado no Clin Cancer Res (2016)

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

Por Albiges, Laurence, Hakimi, A. Ari, Xie, Wanling, McKay, Rana R., Simantov, Ronit, Lin, Xun, Lee, Jae-Lyun, Rini, Brian I., Srinivas, Sandy, Bjarnason, Georg A., Ernst, Scott, Wood, Lori A., Vaishamayan, Ulka N., Rha, Sun-Young, Agarwal, Neeraj, Yuasa, Takeshi, Pal, Sumanta K., Bamias, Aristotelis, Zabor, Emily C., Skanderup, Anders J., Furberg, Helena, Fay, Andre P., de Velasco, Guillermo, Preston, Mark A., Wilson, Kathryn M., Cho, Eunyoung, McDermott, David F., Signoretti, Sabina, Heng, Daniel Y.C., Choueiri, Toni K.
Publicado no J Clin Oncol (2016)